Skip to content

Comparative study on the efficacy and safety of Burst and Tonic mode temporary spinal cord stimulation in the treatment of herpes zoster neuralgia

Comparative study on the efficacy and safety of Burst and Tonic mode temporary spinal cord stimulation in the treatment of herpes zoster neuralgia

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500111111
Enrollment
Unknown
Registered
2025-10-27
Start date
2025-10-27
Completion date
Unknown
Last updated
2025-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

herpes zoster neuralgia

Interventions

Control group:Burst stimulation mode
Test group:Tonic stimulation mode

Sponsors

Affiliated Hospital of Jiangsu Universit
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 95 Years

Inclusion criteria

Inclusion criteria: (1) Age >= 50 years old; (2) Confirmed diagnosis of herpes zoster neuralgia (unilateral spinal nerve dermatome distribution pain + history of rash); (3) The course of disease is 1 to 6 months; (4) Conservative treatment is ineffective (VAS >= 4 points or drug intolerance); (5) No coagulation disorder (INR =100×10?/L); (6) Sign the informed consent form.

Exclusion criteria

Exclusion criteria: ?Systemic diseases: 1) Severe cardiopulmonary insufficiency (NYHA class III/IV or FEV1180mmHg); 3) Diabetic neuropathy (overlapping with ZAP pain). ?Local taboos: 1) Infection at the puncture area or severe spinal deformity; 2) Space-occupying/tuberculosis in the spinal canal (confirmed by MRI/CT); 3) Mental/cognitive impairment: Unable to cooperate with intraoperative testing or follow-up; 4) Implant contraindications: use of pacemakers.

Design outcomes

Primary

MeasureTime frame
Visual Analogue Scale,VAS;Pittsburgh Sleep Quality Index,PSQI;Generalized Anxiety Disorder 7-item scale,GAD-7;Patient Health Questionnaire-9,PHQ-9;

Secondary

MeasureTime frame
Painkiller dosage;Electrode parameter adjustment times;Observation of Adverse Events;

Countries

China

Contacts

Public ContactLi Chunye

Affiliated Hospital of Jiangsu University

372098744@qq.com+86 132 1839 8733

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026